Drugs / Mepivacaine plain
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06047366 Background | Dec 2023 → May 2024 | pulpitis | Indiana University | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mepivacaine plain | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06047366 ↗ |
| Route | Other | “1 cartridge of buffered 2% lidocaine w/ 1:100k epi via inferior alveolar nerve block (IANB) followed by 1 cartridge of 3% mepivacaine via IANB” NCT06047366 ↗ |